Breaking News: New Malaria Breakthrough Emerges as Standard Treatment Fails
A life-saving drug called GanLum has been identified as a promising alternative to treat malaria, a disease that has claimed millions of lives due to resistance to the standard treatment. According to sources, GanLum has shown remarkable effectiveness in combating the malaria parasite.
The new drug comes as a welcome relief after the standard treatment, artemisinins, has shown signs of weakness due to parasite resistance. Experts warn that the deaths from malaria in the late 1990s and early 2000s, which reached 2 million a year, were largely due to drug failure.
GanLum is a new class of drug that has been derived from research and development efforts. It is based on extracts from the sweet wormwood plant, similar to artemisinins, but with a different mechanism of action that may help combat resistance.
The Medicines for Malaria Venture, a non-profit organization, has been at the forefront of malaria research and development. George Jagoe, executive vice president of access and product management, says that GanLum offers new hope for malaria patients.
This breakthrough is a significant development in the fight against malaria, which affects millions of people worldwide. Further research and testing are needed to confirm the effectiveness and safety of GanLum.
This is a developing story, and we will provide updates as more information becomes available.
Share & Engage Share
Share this article